Anticancer immune response and photodynamic therapy

«Radiation and Risk», 2014, vol. 23, No. 4, pp.92-98


Abakushina E.V. – Senior Researcher, C. Sc., Med., A. Tsyb MRRC of A. Hertsen FMRC MH RF, Obninsk, Russia. Contacts: 4 Korolyov str., Obninsk, Kaluga region, Russia, 249036. Tel.: +7 (484) 392-96-04, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. .
Romanko Yu.S. – Head of Dep., MD, A. Tsyb MRRC of A. Hertsen FMRC MH RF, Obninsk, Russia.
Kaplan M.A. – Head of Dep., Prof., MD, A. Tsyb MRRC of A. Hertsen FMRC MH RF, Obninsk, Russia. Kaprin A.D. – Head of Hertsen FMRC MH RF, Corresponding Member of RAS, Prof., MD., A. Tsyb MRRC of A. Hertsen FMRC MH RF, Obninsk, Russia.


Photodynamic therapy (PDT) is a relatively new modality for anticancer treatment. It has been proposed as a promising minimally invasive therapeutic approach that employs three essential elements to induce cell death: a photosensitizer, light of a specific wavelength, and molecular oxygen.The combination of photosensitizer uptake in malignant tissues and selective delivery of light of laser provides effective therapy, with direct tumor cytotoxicity and minimal damage of normal tissue. The photodynamic therapy enhances systemic antitumor immunity and can effectively stimulate both the innate and the adaptive immune systems. It has long been known that the long-term efficacy of PDT depends on the presence of an intact adaptive immune system. It has been shown that PDT can triggering the release of various pro-inflammatory and acute-phase response mediators that lead to infiltration of the treated site by a large number of neutrophils, dendritic cells and lymphocytes. PDT enhances T-cells and natural killer (NK) cells activity. NK cells have been shown to have an indirect effect on the control of tumour growth by PDT. It was demonstrate that tumor cells have increased sensitivity to NK cell lyses following PDT. This review describes the basic mechanisms of action of PDT on the anti-tumor immune response by activation of cytotoxic lymphocytes.

Key words
Рhotodynamic therapy, cancer, NK-cells, receptors, molecules MICA, MHC class I-related molecules, NKG2D, activation of lymphocytes, antitumor immune response, anticancer therapy.


1. Kaplan M.A., Kapinus V.N., Popuchiev V.V., Romanko Yu.S., Yaroslavtseva-Isaeva E.V., Spichenkova I.S., Shubina A.M., Borgul O.V., Goranskaya E.V. Photodynamic therapy: results and prospects. Radiatsi-ya i risk – Radiation and Risk, 2013, vol. 22, no. 3, pp. 115-123. (In Russian).

2. Park M.J., Bae J.H., Chung J.S., Kim S.H., Kang C.D. Induction of NKG2D ligands and increased sensitivity of tumor cells to NK cell-mediated cytotoxicity by hematoporphyrin-based photodynamic therapy. Immunol. Investigat., 2011, vol. 40, pp. 367-382.

3. Buytaert E., Dewaele M., Agostinis P. Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim. Biophys. Acta, 2007, vol. 1776, pp. 86-107.

4. Castano A.P., Mroz P., Hamblin M.R. Photodynamic therapy and anti-tumour immunity. Nat. Rev. Cancer, 2006, vol. 6, pp. 535-545.

5. Ortel B., Shea C.R., Calzavara-Pinton P. Molecular mechanisms of photodynamic therapy. Front. Biosci., 2009, vol. 14, pp. 4157-4172.

6. Korbelik M., Sun J. Cancer treatment by photodynamic therapy combined with adoptive immunotherapy using genetically altered natural killer cell line. Int. J. Cancer, 2001, vol. 93, pp. 269-274.

7. Abakushina E.V., Kuzmina E.G. Stress-induced molecules MICA/B and their role in the development of oncological diseases. Molekuljarnaja medicina – Molecular Medicine, 2012, no. 2, pp. 16-20. (In Russian).

8. Abakushina E.V., Kuzmina E.G., Kovalenko E.I. The main characteristics of human natural killer cells. Immunologija – Immunology, 2012, vol. 33, no. 4, pp. 220-224. (In Russian).

9. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L.L., Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science, 1999, vol. 285, pp. 727-729.

10. Kovalenko E.I., Strelnikova Y.I., Kаnevsky L.M., Abakushina E.V. Effect of the stress-induced molecule MICA on the activity of human natural killer cells. Omskij nauchnyj vestnik – Omsk Scientific Bulletin, 2007, vol. 61, no. 3, pp. 29-31. (In Russian).

11. Abakushina E.V., Klinkova A.V., Kanevskiy L.M., Larin S.S., Kovalenko E.I. Elevation of serum levels of soluble forms of stress-induced molecules MICA in oncological diseases. Molekuljarnaja medicina – Molecular Medicine, 2014, no. 3, pp. 34-38. (In Russian).
12. Belicha-Villanueva A., Riddell J., Naveen B., Gollnick S.O. The Effect of Photodynamic Therapy on Tu-mor Cell Expression of Major Histocompatibility Complex (MHC) Class I and MHC Class I-Related. Molecules Lasers Surg. Med., 2012, vol. 44, no. 1, pp. 60-68.

13. Zhang C., Wang Y., Zhou Z., Zhang J., Tian Z. Sodium butyrate upregulates expression of NKG2D ligand MICA/B in HeLa and HepG2 cell lines and increases their susceptibility to NK lyses. Cancer Immunol. Immunother., 2009, vol. 58, pp. 1275-1285.

Full-text article (in Russian)